Indaptus Therapeutics logo

Indaptus Therapeutics

INDP | NASDAQ
Chart Builder DCF Calculator
$3.45
+$0.28 (+8.83%)
At close: Nov 16, 2026, 4:00 PM ET
$3.45
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:34 PM ET
+8.83%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
30
-2.0 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #793/1021 (Top 78%)

Key Statistics

Market Data

Market Cap $459.69M
1D Range
3.10 3.55
52W Range
0.94 4.75

Valuation (TTM)

PE -0.86
PB 44.49
EV/EBITDA -31.72

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $0.00
Loading financial charts...

Profile

Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral inf...

Sector Healthcare
Industry Biotechnology
Employees 5
IPO Date Aug 4, 2015
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.